RSV Vaccine Study

Participants needed: Healthy babies age 12 to 23 months.

Why are we doing this study: Respiratory Syncytial Virus (RSV) is a virus that can cause infection in the airways.  Symptoms of RSV infection are like the common cold, such as runny nose, cough, sneezing.  There is currently no vaccine to treat RSV.  Researchers want to learn more about a new RSV vaccine that may potentially protect infants from RSV disease.

The study involves: 12 visits over 24 months.  Visits to the study clinic will include a blood test at each visit, questions about your baby’s health, physical exam, nose swabs, and 2 vaccinations.

You will receive: Eligible participants will be reimbursed for travel/ parking with a $40 honorarium at each visit.

To learn more and to see if you are eligible to participate, click here or please contact us.